Pfizer Inc. said it asked U.S. health regulators to authorize its oral Covid-19 drug for use in high-risk patients, which if cleared for use would give people an easy-to-use treatment early in the course of the disease.
A positive decision by the Food and Drug Administration could come before the end of the year, giving patients a pill that they could take at home and keep them out of the hospital this winter.
Read more on wsj.com